sharecast

{{ storiesRelated.title }}

Regulatory News
11 Dec, 2024 09:17 11 Dec, 2024 09:17

Announcement relating to Premium Income

RNS Number : 6846P
China Pacific Insurance Grp Co. Ltd
11 December 2024
 

11 December 2024

CHINA PACIFIC INSURANCE (GROUP) CO., LTD.

China Pacific Insurance (Group) Co., Ltd. (the "Company" or "CPIC") today announces that, for the period between 1 January 2024 and 30 November 2024, the accumulated primary premium income of China Pacific Life Insurance Co., Ltd., a subsidiary of the Company, amounted to RMB228.842 billion, representing a year-on-year increase of 2.2% and the accumulated primary premium income of China Pacific Property Insurance Co., Ltd., a subsidiary of the Company, amounted to RMB187.033 billion, representing a year-on-year increase of 7.0%.

 

The accumulated primary premium income referred to above is unaudited. Investors are advised to take note. Announcement is hereby given.

 

 

Notes:

 

1. The primary premium income was prepared in accordance with the PRC Accounting Standards for Business Enterprises No. 25 - Original Insurance Contracts (Cai Kuai [2006] No.3) and the Regulations regarding the Accounting Treatment of Insurance Contracts (Cai Kuai [2009] No. 15) of the Ministry of Finance of the People's Republic of China.

 

 

2. The accumulated primary premium income of China Pacific Property Insurance Co., Ltd. is the consolidated data including that of Pacific Anxin Agricultural Insurance Co., Ltd., its subsidiary.

 

 

 

 

 

 

By Order of the Board of Directors

China Pacific Insurance (Group) Co., Ltd.

FU Fan

Chairman

 

 

About CPIC

CPIC is a joint stock company established under the laws of the People's Republic of China with limited liability.

CPIC's registered office is located at 1 South Zhongshan Road, Huangpu District, Shanghai, the People's Republic of China.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANAFFFLLFEA